Trends in antidepressant utilization, expenditure, and demographic prescribing patterns in Jordan: a retrospective analysis
Expert Review of Pharmacoeconomics & Outcomes Research · 2026
DOI: 10.1080/14737167.2026.2634759 ↗Kurz gefasst
Fachartikel in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2026. Verfasst von Safa' F Al Twahya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutics and Clinical Pharmacy, The University of Jordan, Amman, Jordan. Hauptthemen laut MEDLINE: Practice Patterns, Physicians', Antidepressive Agents, Health Expenditures. Die Arbeit nennt 45 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The psychological aftermath of the COVID-19 pandemic and ongoing regional stressors have influenced mental health needs in Jordan. Understanding antidepressant utilization and expenditure trends is essential for improving treatment access and resource planning. RESEARCH DESIGN AND METHODS: A retrospective market analysis was conducted using national IQVIA sales data (2019-2023), standardized by the World Health Organization's Defined Daily Dose methodology. Prescription-level data from Advanced Marketing Statistics (AMS) for 2021-2022 were analyzed to assess prescribing patterns by age, gender, and clinical indication. Descriptive and correlation analyses were performed. RESULTS: Antidepressant utilization in Jordan's private sector increased steadily between 2019 and 2023, dominated by selective serotonin reuptake inhibitors (SSRIs), which comprised 79% of total use. Escitalopram was most prescribed (40%), followed by sertraline (18.9%) and citalopram (3.3%). Prescriptions were more frequent among males (55.6%) and adults aged 30-54 years. Major depressive disorder accounted for 46.7% of indications. Fluoxetine use was higher among females, while tricyclic antidepressants were more common in males. CONCLUSIONS: SSRIs, particularly escitalopram, dominate antidepressant prescribing in Jordan's private sector. Patterns vary by age and gender, reflecting clinical diversity. Findings highlight the growing economic burden of antidepressants and the need for cost-containment and targeted mental health strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biopharmaceutics and Clinical Pharmacy, The University of Jordan, Amman, Jordan.
- Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
ORCID-Profile: Safa' F Al Twahya, Rima Hijazeen, Hamzeh Almomani, Qais Alefan, Ibrahim Alabbadi
Zitieren
APA
Al Twahya, S. F., Hijazeen, R., Almomani, H., Alefan, Q., & Alabbadi, I. (2026). Trends in antidepressant utilization, expenditure, and demographic prescribing patterns in Jordan: a retrospective analysis. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2026.2634759
Vancouver
Al Twahya SF, Hijazeen R, Almomani H, Alefan Q, Alabbadi I. Trends in antidepressant utilization, expenditure, and demographic prescribing patterns in Jordan: a retrospective analysis. Expert Review of Pharmacoeconomics & Outcomes Research. 2026. doi:10.1080/14737167.2026.2634759
BibTeX
@article{AlTwahya2026,
author = {Al Twahya, Safa' F and Hijazeen, Rima and Almomani, Hamzeh and Alefan, Qais and Alabbadi, Ibrahim},
title = {Trends in antidepressant utilization, expenditure, and demographic prescribing patterns in Jordan: a retrospective analysis},
journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
year = {2026},
doi = {10.1080/14737167.2026.2634759}
}
EUVIMED